Cannabis B2B supply partner evaluation is one of the most consequential decisions an importer, pharmaceutical distributor, or downstream buyer can make. Regulatory enforcement in Germany, Australia, and Israel has tightened considerably since 2024, and a supplier that fails a shipment-level inspection or a GMP audit can disrupt an entire market position. The questions a buyer asks before signing a supply agreement matter more now than they did three years ago.
This guide outlines the criteria that sophisticated importers use to vet Canadian Licensed Producers: what documentation to request, which compliance signals actually matter, and where most supplier relationships fail before a single shipment clears customs.
Regulatory standing and licensing documentation
The baseline requirement for any Canadian cannabis supply partner is an active Health Canada licence: specifically a Standard Cultivation licence or a processing licence authorising the applicable product category. A licence number is public and verifiable through Health Canada's online registry. Any supplier that hedges on this should not advance past initial inquiry.
Beyond domestic licensing, the supplier must hold export authorisation under the Cannabis Act for each destination country. Export permits are issued per shipment in Canada, which means asking whether a supplier has "export authorisation" is not the same as asking whether they have shipped to your jurisdiction before. Request a record of completed export permits, including destination countries and approximate volumes, to confirm operational history rather than theoretical eligibility.
For the German medical channel specifically, EU-GMP certification (or a written EU-GMP equivalency declaration from a European Qualified Person) is a condition of entry. A Health Canada GMP Certificate of Compliance covers Canadian regulatory requirements. It does not automatically satisfy EU importers or the BfArM documentation expectations. Confirm which certification applies to the specific batch being purchased, not to the facility in general.
What to request
- Current Health Canada licence number and class
- Health Canada GMP Certificate of Compliance (current issuance date)
- EU-GMP certificate or QP documentation for EU-bound shipments
- Sample export permit from a recent completed shipment
Quality systems and batch testing standards
A supplier's quality system tells you more about supply reliability than any sales presentation. The minimum standard for B2B buyers should be ISO/IEC 17025-accredited laboratory testing for all batch-level Certificates of Analysis (COA). ISO 17025 accreditation means the testing laboratory has been independently assessed for technical competence and measurement accuracy. A COA from a non-accredited lab carries materially more risk for buyers who must satisfy their own regulators downstream.
Request a sample COA from a recent production batch and review the following: cannabinoid potency (THC, CBD, CBG at minimum), terpene panel if applicable, microbial testing (total aerobic count, E. coli, Salmonella, mould and yeast), heavy metal screen, pesticide residue panel, and moisture content. For Australian buyers operating under TGO 93, the specific limits on microbial and pesticide parameters are defined by regulation. Confirm the COA panel maps to those limits before signing.
Batch-to-batch consistency is a separate question from batch quality. Ask for three to five consecutive COAs from the same cultivar and compare THC variance. High variance across batches (more than 2-3% THC swing) creates downstream compliance exposure and signals cultivation or processing instability, regardless of whether any single batch passes its tests.
The B2B Batch Quality Checklist
| Parameter | Why it matters | What to look for |
|---|---|---|
| ISO 17025 lab accreditation | Regulatory defensibility | Accreditation certificate, lab name on COA |
| THC/CBD consistency (multi-batch) | Supply reliability | <2% variance across 3 batches |
| Microbial panel completeness | Mandatory for medical channels | E. coli, Salmonella, mould/yeast, TAMC |
| Pesticide panel scope | TGO 93 / EU import compliance | Full screening, not spot-check |
| Shelf-life data | Inventory planning, customs clearance timing | Stability study or minimum shelf-life declaration |
Product specifications and cultivation standards
Dried flower for B2B medical channels is not a commodity. Pharmacy distributors, wholesalers, and end-use medical channels apply varying specifications for moisture content, bud size, trim quality, and visual presentation. Before evaluating price, establish whether the supplier's production output actually meets the product specification your channel requires.
Indoor cultivation produces a more controlled output than greenhouse or outdoor: stable light cycles, regulated humidity, and climate control translate into consistent cannabinoid expression and terpene preservation. For pharmaceutical distribution channels that require defined product specifications in their supply agreements, indoor-grown flower is lower risk to specify than mixed-source or outdoor flower.
Hand-trimming is a meaningful differentiator in markets where pharmacy presentation standards are high. Machine trimming is faster but removes more surface trichomes and can damage bud structure. Ask the supplier directly how they trim and request visual samples or images of the finished flower. A supplier confident in their trimming standards will share this without hesitation.
Where cultivar genetics matter to your market (particularly in Germany, where some importers track cultivar provenance for prescriber preference data), ask for cultivar origin documentation and any phenotype selection records. This is increasingly relevant as the German medical channel builds its own prescribing history datasets.
Traceability, documentation, and supply chain reliability
Full traceability from seed to export is not a marketing statement. It is an audit requirement under Health Canada's Cannabis Regulations, and downstream regulators in Germany, Australia, and Israel increasingly ask for traceability documentation as part of import clearance. Ask the supplier how they document lot-to-batch linkage and whether they can provide a chain-of-custody record from cultivation lot to packaged export unit.
Supply chain reliability is harder to assess from documents alone. The most useful questions to ask during due diligence:
- What is your current inventory position for this cultivar, and how many months of consistent supply can you commit to?
- What is your typical lead time from purchase order to export-ready packaging?
- Have you had any export shipments refused or held in the past 18 months, and what was the reason?
- Do you work with a licensed customs broker experienced in narcotic import permits for the destination country?
A supplier who cannot answer these questions with specifics has either not exported to your jurisdiction before or is not yet operationally ready for a sustained supply relationship. Both are material risks worth surfacing before a contract is signed.
Ask for at least two verifiable reference contacts from existing B2B customers in your region or in comparable regulated markets. A Canadian LP with active German, Australian, or Israeli supply relationships should be able to provide this without delay. Learn more about the Health Canada export permit process or our compliance certifications.
AlphaLeaf is a Montreal-based Health Canada Licensed Producer of indoor-grown, hand-trimmed cannabis flower, with export authorisation under the Cannabis Act. Our batches are ISO 17025-tested, fully traceable from cultivation lot to export unit, and accompanied by the GMP documentation and COA packages that medical importers in Germany, Australia, and Israel require. For B2B buyers building or expanding their Canadian supply relationships, we provide the compliance documentation, cultivar consistency, and supply capacity that regulated channels demand.
Frequently Asked Questions
What documents should I request from a Canadian cannabis LP before signing a supply agreement?
At minimum, request the supplier's Health Canada licence number, a current GMP Certificate of Compliance, recent ISO 17025-accredited COAs for the specific cultivar, export permit records from completed shipments, and verifiable B2B customer references. For EU-bound shipments, also request EU-GMP certification or QP equivalency documentation.
How do I verify that a Canadian LP is authorised to export cannabis to my country?
Confirm the supplier holds an active Health Canada licence through the public Health Canada registry, then ask for documentation of completed export permits to your specific jurisdiction. Export permits in Canada are issued per shipment, so prior completed exports are the clearest evidence of operational export capability. For Germany, also confirm EU-GMP standing with the relevant Qualified Person.
What is ISO 17025 accreditation and why does it matter for cannabis COAs?
ISO/IEC 17025 is the international standard for testing laboratory competence, covering sampling, testing, calibration, and reporting. A COA from an ISO 17025-accredited lab has been produced by a facility that has been independently assessed for technical accuracy and consistency. For regulated medical cannabis channels, this accreditation is the standard of evidence for batch quality data.
How much batch-to-batch THC variance is acceptable in a B2B cannabis supply relationship?
A variance of more than 2-3% THC across consecutive batches of the same cultivar is a signal worth investigating. High variance can create compliance exposure for downstream channels that have defined product specifications or prescriber expectations tied to a consistent cannabinoid profile. Always request three to five consecutive COAs before committing to a supply agreement.
What should I look for in a cannabis COA for Australian TGO 93 compliance?
TGO 93 sets specific limits for microbial contaminants, heavy metals, pesticide residues, and moisture content in therapeutic cannabis products. Review the COA against the applicable TGO 93 limits for each parameter category. Confirm the testing laboratory is ISO 17025-accredited and that the COA includes all required panel categories, not only the parameters the supplier chose to test.
